Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

Immunomedics (IMMU) is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. This stock closed up 9.8% to $6.81 in Tuesday's trading session.

From a technical perspective, IMMU soared higher here right above some near-term support at $5.93 with monster upside volume. This move pushed shares of IMMU into breakout territory, since the stock took out some near-term overhead resistance levels at $6.39 to $6.70. Shares of IMMU are now quickly moving within range of triggering another big breakout trade. That trade will hit if IMMU manages to clear Tuesday's high of $6.81 and its 52-week high at $6.91 with high volume.

Traders should now look for long-biased trades in IMMU as long as it's trending above $6.39 or above its 50-day at $5.79 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.05 million shares. If that breakout hits soon, then IMMU will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $8 to $10.

Pain Therapeutics

Pain Therapeutics (PTIE) is a biopharmaceutical company that develops novel drugs. This stock closed up 9.9% to $2.99 in Tuesday's trading session.

From a technical perspective, PTIE ripped sharply higher here back above its 200-day moving average of $2.83 with above-average volume. This move pushed shares of PTIE into breakout territory, since the stock took out some key overhead resistance levels at $2.82 to $2.84. That breakout also pushed shares of PTIE above the upper-end of its recent base, which saw the stock trade between $2.48 on downside and $2.84 on the upside.

Traders should now look for long-biased trades in PTIE as long as it's trending above its 50-day at $2.57 or above more support at $2.48 and then once it sustains a move or close above Tuesday's high of $3.01 with volume that hits near or above 277,750 shares. If we get that move soon, then PTIE will set up to re-test or possibly take out its next major overhead resistance level at $3.45. Any high-volume move above $3.45 will then give PTIE a chance to re-fill some of its previous gap down zone from May that started near $5.50.

Antares Pharma

Antares Pharma (ATRS) is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. This stock closed up 7.3% to $4.36 in Tuesday's trading session.

From a technical perspective, ATRS spiked sharply higher here right above its 200-day moving average of $3.99 and back above its 50-day moving average of $4.34 with monster upside volume. This move is quickly pushing shares of ATRS within range of triggering a major breakout trade. That trade will hit if ATRS manages to take out some near-term overhead resistance levels at $4.45 to its 52-week high at $4.67 with high volume.

Traders should now look for long-biased trades in ATRS as long as it's trending above Tuesday's low of $4.15 or above its 200-day at $3.99, and then once it sustains a move or close above those breakout levels with volume that hits near or above 926,105 shares. If that breakout hits soon, then ATRS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $5 to $5.58.

Biolase

Biolase (BIOL) is a medical technology company that develops, manufactures and markets laser systems for dental and medical applications. This stock closed up 4% to $1.99 in Tuesday's trading session.

From a technical perspective, BIOL trended higher here right above some near-term support at $1.80 with lighter-than-average volume. This stock has been uptrending strong for the last two months, with shares soaring higher from its low of $1.15 to its recent high of $2.24. During that uptrend, shares of BIOL have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BIOL within range of triggering a major breakout trade. That trade will hit if BIOL manages to take out some near-term overhead resistance levels at $2.15 to $2.24 and then once it clears its 50-day moving average of $2.29 with high volume.

Traders should now look for long-biased trades in BIOL as long as it's trending above some key near-term support at $1.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 649,105 shares. If that breakout triggers soon, then BIOL will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to its 200-day moving average at $3.39.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.